Spyre Therapeutics Inc. (SYRE) — Free Cash Flow Generation Index
Latest as of June 2021:
0.99x
Spyre Therapeutics Inc. (SYRE) has a Free Cash Flow Generation Index of 0.99x as of June 2021. Free cash flow of $2.05 Million represents 1% of operating cash flow ($2.08 Million). Explore Spyre Therapeutics Inc. capital spending ratio to see what proportion of operating cash flow is directed to capital expenditures.
FCF Generation Index
0.99x
Free Cash Flow / Operating CF
Free Cash Flow
$2.05 Million
USD
Operating Cash Flow
$2.08 Million
USD
Capital Expenditures
$30.00K
USD
Annual Free Cash Flow Generation for Spyre Therapeutics Inc. (None–None)
Year-by-year Free Cash Flow Generation Index for Spyre Therapeutics Inc.. Check cash flow reinvestment rate of Spyre Therapeutics Inc. to assess the company's total reinvestment commitment from operating cash flow.
| Year | FCG Index | Free Cash Flow (USD) | Operating CF | Capital Expenditures | YoY Change |
|---|
FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).